Get the Stockscreener App
2.545
13.62%
0.305
Pre-market:
2.52
-0.025
-0.98%
Whitehawk Therapeutics Inc stock is traded at $2.545, with a volume of 382.09K.
It is up +13.62% in the last 24 hours and up +12.61% over the past month.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
See More
Previous Close:
$2.24
Open:
$2.25
24h Volume:
382.09K
Relative Volume:
0.23
Market Cap:
$119.94M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+10.65%
1M Performance:
+12.61%
6M Performance:
+50.59%
1Y Performance:
+0.00%
1-Day Range:
$2.23
$2.55
1-Week Range:
$2.18
$2.55
52-Week Range:
$1.39
$3.7699
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Name
Whitehawk Therapeutics Inc
Sector
Industry
Phone
551-321-2234
Address
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
2.545 | 105.57M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-21-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-21-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-15-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-11-22 | Initiated | Jefferies | Buy |
| Oct-01-21 | Initiated | Cowen | Outperform |
| Sep-14-21 | Initiated | Ladenburg Thalmann | Buy |
| Sep-08-21 | Initiated | Piper Sandler | Overweight |
View All
Whitehawk Therapeutics Inc Stock (WHWK) Latest News
Comparing Whitehawk Therapeutics (NASDAQ:WHWK) & Acerus Pharmaceuticals (OTCMKTS:TRLPF) - Defense World
Will Whitehawk Therapeutics Inc. (3350) stock profit from automation waveQuarterly Performance Summary & Risk Managed Trade Strategies - Newser
How Whitehawk Therapeutics Inc. stock performs in stagflationJuly 2025 Retail & Safe Capital Investment Plans - Newser
How Whitehawk Therapeutics Inc. stock compares to market leadersJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - Newser
Why Whitehawk Therapeutics Inc. (3350) stock stays resilientWeekly Gains Report & Expert Approved Trade Ideas - Newser
Can Whitehawk Therapeutics Inc. stock beat analyst upgradesJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
Will Whitehawk Therapeutics Inc. (3350) stock benefit from commodity supercycleJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - Newser
How Whitehawk Therapeutics Inc. (3350) stock compares with top peersJuly 2025 Trade Ideas & Stock Portfolio Risk Management - Newser
What analysts say about Whitehawk Therapeutics Inc 3350 stockValue Stock Picks & Free Stock Trading Workshops - earlytimes.in
How Whitehawk Therapeutics Inc. (3350) stock trades after earnings2025 Risk Factors & Safe Capital Growth Trade Ideas - Newser
Is Whitehawk Therapeutics Inc. (3350) stock worth buying before Fed actionJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - Newser
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer - citybiz
Whitehawk therapeutics names Margaret Dugan as chief medical officer - Investing.com
Whitehawk Therapeutics appoints Margaret Dugan as chief medical officer - marketscreener.com
Whitehawk therapeutics names Margaret Dugan as chief medical officer By Investing.com - Investing.com Australia
Whitehawk Therapeutics Appoints Margaret Dugan, As Chief Medical Officer - TradingView
Published on: 2025-11-30 18:46:11 - BỘ NỘI VỤ
What risks investors should watch in Whitehawk Therapeutics Inc. stockQuarterly Earnings Report & Short-Term High Return Ideas - BỘ NỘI VỤ
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress
Whitehawk Therapeutics (Nasdaq: WHWK) at Piper Sandler 37th Conference on Dec. 3 - Stock Titan
What analysts say about Whitehawk Therapeutics Inc stockSupport Level Holds & High Return Capital Gain - earlytimes.in
Is Whitehawk Therapeutics Inc. stock positioned well for digital economyWeekly Gains Report & Verified Swing Trading Watchlist - newser.com
Whitehawk Therapeutics stock holds steady as Jefferies maintains rating By Investing.com - Investing.com Canada
Whitehawk Therapeutics stock holds steady as Jefferies maintains rating - Investing.com
Can Whitehawk Therapeutics Inc. (3350) stock withstand sector downturnsAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
Will Whitehawk Therapeutics Inc. (3350) stock deliver stable dividends2025 Biggest Moves & AI Driven Stock Reports - newser.com
Multi asset correlation models including Whitehawk Therapeutics Inc.July 2025 Catalysts & Weekly Momentum Picks - newser.com
Published on: 2025-11-19 15:47:46 - newser.com
Candlestick signals on Whitehawk Therapeutics Inc. stock today2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Smart tools for monitoring Whitehawk Therapeutics Inc.’s price actionMarket Rally & Advanced Technical Signal Analysis - newser.com
How Whitehawk Therapeutics Inc. stock performs after earningsRate Cut & Long-Term Capital Growth Strategies - newser.com
Whitehawk Therapeutics Inc Stock (WHWK) Financials Data
There is no financial data for Whitehawk Therapeutics Inc (WHWK). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):